Our Bond, Inc. (NASDAQ: OBAI) said it signed a phase 1 commercial agreement worth about $250,000 with one of the world’s five largest pharmaceutical companies. The deal covers deployment of Bond’s AI-powered personal security platform for 5,000 employees in the United States and is expected to add about $250,000 in annual recurring revenue, with potential expansion that could lift cumulative contract value beyond $1 million over time.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TG-17 Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202602230837PRIMZONEFULLFEED9659139) on February 23, 2026, and is solely responsible for the information contained therein.